General Information of Drug Transporter (DT)
DT ID DTD0474 Transporter Info
Gene Name SLC7A7
Transporter Name Y+L amino acid transporter 1
Gene ID
9056
UniProt ID
Q9UM01
Post-Translational Modification of This DT
Overview of SLC7A7 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC7A7 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

325

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC7A7 Asparagine 325 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC7A7 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

4

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Serine 4 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC7A7 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

11

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Serine 11 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC7A7 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

18

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Serine 18 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC7A7 [2] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

25

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Serine 25 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC7A7 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

339

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Serine 339 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC7A7 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

5

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Threonine 5 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC7A7 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

17

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Threonine 17 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC7A7 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

7

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC7A7 Tyrosine 7 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: YLAT1_HUMAN)
2 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
3 Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. Proteomics. 2017 Nov;17(22):10.1002/pmic.201700214.
4 Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines. J Proteomics. 2015 Sep 8;127(Pt B):247-58.
5 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
6 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
7 Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.